The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age

SIMPLE SUMMARY: About 35% of patients with multiple myeloma are ≥75 years old at diagnosis, and their treatment should be individualized according to their fragility score. Fragility assessment scales include the International Myeloma Working Group Palumbo Fragility Scale, the Revised Initial Myelom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyczyńska, Agata, Krzempek, Marcela Krzysława, Cortez, Alexander Jorge, Jurczyszyn, Artur, Godlewska, Katarzyna, Ciepłuch, Hanna, Subocz, Edyta, Hałka, Janusz, Kulikowska de Nałęcz, Anna, Wiśniewska, Anna, Świderska, Alina, Waszczuk-Gajda, Anna, Drozd-Sokołowska, Joanna, Guzicka-Kazimierczak, Renata, Wiśniewski, Kamil, Porowska, Agnieszka, Knopińska-Posłuszny, Wanda, Kłoczko, Janusz, Rzepecki, Piotr, Woszczyk, Dariusz, Symonowicz, Hanna, Basak, Grzegorz Władysław, Zdziarska, Barbara, Jamroziak, Krzysztof, Zaucha, Jan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340664/
https://www.ncbi.nlm.nih.gov/pubmed/37444579
http://dx.doi.org/10.3390/cancers15133469

Ejemplares similares

Ejemplares similares